Literature DB >> 12441087

Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector.

Koji Ishii1, Yoshiaki Ueda, Kazuhiro Matsuo, Yoshiharu Matsuura, Takashi Kitamura, Kenzo Kato, Yasuyuki Izumi, Kenji Someya, Takeaki Ohsu, Mitsuo Honda, Tatsuo Miyamura.   

Abstract

DIs is a restrictive host range mutant of vaccinia virus strain DIE that grows well only in chick embryo fibroblast cells but is unable to grow in most mammalian cells. In this study, we identified one major deletion (15.4 kbp) which results in the loss of 19 putative open reading frames in the left end of the genome. We then established a system to express foreign genes by inserting them into the deleted region of DIs. We constructed rDIs to express the bacteriophage T7 polymerase (T7pol) gene and showed the expression in various mammalian cell lines by reporter luciferase gene expression under the T7 promoter. We also expressed the full-length human immunodeficiency virus (HIV)-1 NL432 gag gene. The expressed gag gene product induced high levels of cytotoxic T lymphocytes in immunized mice. These data suggest that DIs is useful as an efficient, transient replication-deficient viral vector.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441087     DOI: 10.1006/viro.2002.1622

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

1.  Rearranged genomic RNA segments offer a new approach to the reverse genetics of rotaviruses.

Authors:  Cécile Troupin; Axelle Dehée; Aurélie Schnuriger; Patrice Vende; Didier Poncet; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

2.  A post-entry step in the mammalian orthoreovirus replication cycle is a determinant of cell tropism.

Authors:  Laura S Ooms; Takeshi Kobayashi; Terence S Dermody; James D Chappell
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

3.  Dual selection mechanisms drive efficient single-gene reverse genetics for rotavirus.

Authors:  Shane D Trask; Zenobia F Taraporewala; Karl W Boehme; Terence S Dermody; John T Patton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

4.  Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus.

Authors:  Satoshi Komoto; Jun Sasaki; Koki Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

5.  Generation of recombinant rotavirus with an antigenic mosaic of cross-reactive neutralization epitopes on VP4.

Authors:  Satoshi Komoto; Masanori Kugita; Jun Sasaki; Koki Taniguchi
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

Review 6.  Vaccinia virus vaccines: past, present and future.

Authors:  Bertram L Jacobs; Jeffrey O Langland; Karen V Kibler; Karen L Denzler; Stacy D White; Susan A Holechek; Shukmei Wong; Trung Huynh; Carole R Baskin
Journal:  Antiviral Res       Date:  2009-06-26       Impact factor: 5.970

7.  Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression.

Authors:  Aleksander A Demidenko; Joseph N Blattman; Negin N Blattman; Philip D Greenberg; Max L Nibert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

8.  Identification of functional domains in reovirus replication proteins muNS and mu2.

Authors:  Takeshi Kobayashi; Laura S Ooms; James D Chappell; Terence S Dermody
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.

Authors:  Kenji Someya; Ke-Qin Xin; Kazuhiro Matsuo; Kenji Okuda; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 10.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.